Join the club for FREE to access the whole archive and other member benefits.

Five Alarm Bio

Company that develops drugs to slow down the ageing process

Anti-aging science has enormous potential. Age-related diseases such as cancer, neurodegenerative diseases are among the leading causes of death and a significant burden on health funding.

Five Alarm Bio is developing a small molecule approach to boost the body’s defence to aging, based on a new understanding of how the chemical damage associated with age accumulates in cells. In addition to a broad range of age-related diseases, Five Alarm Bio sees relevance of its platform for cosmeceuticals.

Founded in 2016 by three experienced entrepreneurs, Five Alarm Bio is based near Cambridge, UK, and is carrying out research at the Babraham Campus.

Visit website: http://www.fivealarmbio.com/

 five-alarm-bio-limited

Details last updated 07-Nov-2020

People at Five Alarm Bio

Janette Thomas

Chief Executive Officer at Five Alarm Bio Limited

William Bains

Senior Research Fellow at Cardiff University, Co-founder and CSO at Five Alarm Bio

Five Alarm Bio News

Five Alarm Bio raises seed investment to discover small molecule anti-aging drugs

Cambridge Network - 27-Feb-2023

No drug candidates yet, but great to see investors willing to support a broad attack on ageing

Read more...

Five Alarm Bio to develop drug treatment not to cure ageing but improve healthy lifespan

Cambridge Independent - 04-Nov-2022

The company aims at treatments for a range of diseases associated with ageing and disabilities

Read more...
Topics mentioned on this page:
Ageing Research